Biotech Archives - Page 16 of 54 - Life Sciences Times

Beneath the biotech boom

April 17, 2025

Podimetrics and HealthMed Partner to Expand Diabetes Complication Prevention for Employers and Healthcare Systems

April 17, 2025

Novartis to Invest $23 Billion in Expanding U.S. Manufacturing and Research Footprint

April 13, 2025

THIS WEEK'S STORIES

Harvard Bioscience Announces CFO Transition

April 14, 2025

MindMed Doses First Patient in Phase 3 Trial of LSD-Based Therapy for Major Depressive Disorder

April 15, 2025

City Therapeutics Strengthens Executive Leadership and Board as It Prepares for Clinical Milestone

April 17, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Beneath the biotech boom

Biostate AI and Accelerated Cure Project Partner to Develop AI Models for Predicting Multiple Sclerosis Progression and Treatment Response

Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Carlsbad to Accelerate Cell Therapy Development

Third Harmonic Bio Announces Plan to Liquidate and Dissolve Company

Profluent Unveils ProGen3, Marking a Milestone in AI-Powered Protein Design

Most Read

Alis Biosciences Launches Fund to Unlock $30 Billion in Trapped Capital from Struggling Biotech Firms

$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals

Tempus Forms Advisory Board of Leading Physicians to Guide AI-Driven Precision Medicine

Beneath the biotech boom

EDITOR PICKS

Beneath the biotech boom

Podimetrics and HealthMed Partner to Expand Diabetes Complication Prevention for Employers and Healthcare Systems

Novartis to Invest $23 Billion in Expanding U.S. Manufacturing and Research Footprint

THIS WEEK'S STORIES

Harvard Bioscience Announces CFO Transition

MindMed Doses First Patient in Phase 3 Trial of LSD-Based Therapy for Major Depressive Disorder

City Therapeutics Strengthens Executive Leadership and Board as It Prepares for Clinical Milestone

POPULAR CATEGORY

ABOUT US

FOLLOW US